Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000711049 | SCV000841376 | benign | not provided | 2018-05-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001001577 | SCV001012699 | benign | Cerebral cavernous malformation 2 | 2024-01-23 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001001577 | SCV001158975 | benign | Cerebral cavernous malformation 2 | 2023-06-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000711049 | SCV004156864 | benign | not provided | 2022-03-01 | criteria provided, single submitter | clinical testing | CCM2: BS1, BS2 |
Prevention |
RCV003928179 | SCV004741929 | likely benign | CCM2-related disorder | 2021-04-28 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000711049 | SCV001918039 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727796 | SCV001969125 | benign | not specified | no assertion criteria provided | clinical testing |